China
· Delayed Price · Currency is CNY Frontier Biotechnologies Statistics
Total Valuation
SHA:688221 has a market cap or net worth of CNY 3.21 billion. The enterprise value is 3.00 billion.
| Market Cap | 3.21B |
| Enterprise Value | 3.00B |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688221 has 374.58 million shares outstanding. The number of shares has decreased by -0.17% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 374.58M |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | +1.85% |
| Owned by Insiders (%) | 16.08% |
| Owned by Institutions (%) | 1.62% |
| Float | 204.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.82 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.89 |
| EV / Sales | 23.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.17% and return on invested capital (ROIC) is -7.57%.
| Return on Equity (ROE) | -16.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.57% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 327,780 |
| Profits Per Employee | -510,170 |
| Employee Count | 395 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.67% in the last 52 weeks. The beta is 0.76, so SHA:688221's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +39.67% |
| 50-Day Moving Average | 9.35 |
| 200-Day Moving Average | 7.67 |
| Relative Strength Index (RSI) | 44.49 |
| Average Volume (20 Days) | 3,535,636 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688221 had revenue of CNY 129.47 million and -201.52 million in losses. Loss per share was -0.54.
| Revenue | 129.47M |
| Gross Profit | 129.47M |
| Operating Income | -201.23M |
| Pretax Income | -201.52M |
| Net Income | -201.52M |
| EBITDA | -177.65M |
| EBIT | -201.23M |
| Loss Per Share | -0.54 |
Balance Sheet
The company has 662.47 million in cash and 448.63 million in debt, giving a net cash position of 213.83 million or 0.57 per share.
| Cash & Cash Equivalents | 662.47M |
| Total Debt | 448.63M |
| Net Cash | 213.83M |
| Net Cash Per Share | 0.57 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 3.07 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -155.42% and -155.64%.
| Gross Margin | 100.00% |
| Operating Margin | -155.42% |
| Pretax Margin | -155.64% |
| Profit Margin | -155.64% |
| EBITDA Margin | -137.21% |
| EBIT Margin | -155.42% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688221 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.17% |
| Shareholder Yield | 0.17% |
| Earnings Yield | -6.27% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |